48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis

por Patel, Dipen A., Snedecor, Sonya J., Tang, Wing Yu, Sudharshan, Lavanya, Lim, Jessica W., Cuffe, Robert, Pulgar, Sonia, Gilchrist, Kim A., Camejo, Rodrigo Refoios, Stephens, Jennifer, Nichols, Garrett
Publicado 2014